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Abstract
The chromosome of Mycobacterium tuberculosis (Mtb) encodes forty seven toxin-antitoxin modules belonging to the VapBC
family. The role of these modules in the physiology of Mtb and the function(s) served by their expansion are unknown. We
investigated ten vapBC modules from Mtb and the single vapBC from M. smegmatis. Of the Mtb vapCs assessed, only
Rv0549c, Rv0595c, Rv2549c and Rv2829c were toxic when expressed from a tetracycline-regulated promoter in M. smegmatis.
The same genes displayed toxicity when conditionally expressed in Mtb. Toxicity of Rv2549c inM. smegmatis correlated with
the level of protein expressed, suggesting that the VapC level must exceed a threshold for toxicity to be observed. In
addition, the level of Rv2456 protein induced in M. smegmatis was markedly lower than Rv2549c, which may account for the
lack of toxicity of this and other VapCs scored as ‘non-toxic’. The growth inhibitory effects of toxic VapCs were neutralized
by expression of the cognate VapB as part of a vapBC operon or from a different chromosomal locus, while that of non-
cognate antitoxins did not. These results demonstrated a specificity of interaction between VapCs and their cognate VapBs,
a finding corroborated by yeast two-hybrid analyses. Deletion of selected vapC or vapBC genes did not affect mycobacterial
growth in vitro, but rendered the organisms more susceptible to growth inhibition following toxic VapC expression.
However, toxicity of ‘non-toxic’ VapCs was not unveiled in deletion mutant strains, even when the mutation eliminated the
corresponding cognate VapB, presumably due to insufficient levels of VapC protein. Together with the ribonuclease (RNase)
activity demonstrated for Rv0065 and Rv0617 – VapC proteins with similarity to Rv0549c and Rv3320c, respectively – these
results suggest that the VapBC family potentially provides an abundant source of RNase activity in Mtb, which may
profoundly impact the physiology of the organism.
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Introduction
The feature of Mtb that presents the most significant impediment
to developing treatment-shortening therapies for tuberculosis (TB) is
its remarkable ability to persist in the face of the threats imposed by
host immunity and bactericidal drug action [1,2,3]. This ability is
thought to account, at least in part, for the protracted duration of
treatment required to cure TB with short-course chemotherapy.
Thus, understanding the physiology of the persistent state/s in Mtb
represents one of the most important areas of mycobacterial
research today [1,3,4]. Much emphasis has been placed on defining
the physiology of non-replicating persister cells of Mtb formed
under the conditions of nutritional, hypoxic, nitrosative and acidic
stress thought to be encountered during infection [5,6]. This has led
to the identification of pathways that are required to maintain
mycobacterial viability under such conditions and whose compo-
nents are being pursued as novel drug targets [7,8,9,10,11].
Attention has also focused on the mechanisms underlying the
formation of persister cells that arise through the stochastic
expression of proteins that can affect the physiology and growth
rate of the cell by interfering with key cellular processes such as
macromolecular synthesis [2,12,13,14,15,16,17,18,19,20]. These
mechanisms are the subject of considerable interest having been
implicated in phenotypic drug tolerance/indifference in E. coli
[2,14,15,16,17,18,21,22,23].
Of the genes implicated in such processes, most attention has been
paid to toxin-antitoxin (TA) modules, which are bicistronic operons
widely distributed in the genomes of free-living prokaryotes [24,25].
Although their contemporary role in microbial physiology remains the
subject of debate [26,27], there is evidence that chromosomal TA
modules may act in stress physiology by serving as metabolic
regulators of growth [13,25,28,29]. When bound in a complex, the
antitoxin neutralizes the activity of the toxin [30,31,32]. In the absence
of continued expression of the operon, which regulates its own
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expression [33], dissociation of the complex and degradation of the
relatively unstable antitoxin unveils the biological activity of the toxin.
Mtb possesses an unusually large and diverse complement of
TA modules which belong to the MazEF, RelBE, ParDE, HigBA
and VapBC families [24,25]. A systematic analysis of Mtb TA
module function revealed that Mtb also possesses a number of
novel systems with no similarity to known modules [34]. Within
this repertoire, the paralogous expansion of the VapBC family is
particularly noteworthy [24,25,35,36] and is a feature that Mtb
shares with a small number of unrelated organisms [37]. In stark
contrast, the genomes of mycobacteria other than those belonging
to the Mtb complex (M. africanum,M. microti,M. canetti andM. bovis)
are virtually devoid of VapBC and other TA modules [34]. The
TA modules of Mtb have been the subject of intense investigation
[31,34,38,39,40,41,42,43,44,45]. Of the 47 VapBC modules (Fig.
S1), one has been structurally and biochemically characterized
[31], and this and 22 others tested for toxicity in E. coli [40,45].
Twenty one of 45 VapCs tested were found to be toxic in M.
smegmatis and four of these were shown to inhibit translation [34].
VapC toxins belong to the PIN (PilT N-terminus) domain family
of proteins whose members have been associated with nuclease
activity [36]. Most recently, enteric VapCs were shown to act as
site-specific endonucleases that inhibit translation by cleavage of
initiator tRNA [46]. PIN domains have RNase-H-like fold in
which four conserved acidic residues are located in close proximity
to form a negatively charged pocket, as illustrated in the structures
of the VapC from Pyrobaculum aerophilum [47,48], VapC5 from Mtb
[31] and FitB from Neisseria gonorrhoeae [32]. Dissociation of the
toxin-antitoxin complex is thought to allow binding of divalent
metal ion in this acidic pocket of VapC thereby creating an active
site for metal-ion-dependent nuclease activity [32,48].
To investigate vapBC function in mycobacteria, we focused on a
subset of 10 modules from Mtb H37Rv and the single vapBC from
M. smegmatis mc2155. We found that some, but not all of the VapC
proteins confer growth inhibition following inducible over-
expression in both mycobacterial species. The toxic activity of
these VapCs could be neutralized by the cognate, but not non-
cognate antitoxins, indicating that these loci encode functional
VapBC modules. A correlation between the expression levels of
the VapC proteins and its ability to confer a toxic phenotype was
observed. Analysis of mycobacterial vapBC deletion mutants failed
to yield observable phenotypes under standard growth conditions.
However, toxic VapCs showed enhanced toxicity when expressed
in deletion mutants lacking antitoxic VapCs, providing further
evidence of the specificity of interaction between VapCs and their
cognate antitoxins, as revealed by yeast two-hybrid analyses of
VapB-VapC interactions. Finally, the VapCs, Rv0065 and
Rv0617, which share ,50% sequence similarity to the toxic
VapCs, Rv0549c and Rv3320c, respectively, were shown to have
sequence-selective, Mg2+-dependent RNase activity, further con-
firming an association between VapC toxicity, translational
inhibition and RNA cleavage. We discuss the implications of
these findings for the physiology of Mtb.
Results
VapBC modules selected for study
A subset of VapBCmodules in Mtb was selected for study with the
choice being guided, in part, by information on transcriptional
responsiveness and/or essentiality of vapBC gene function available at
the time (Table S1). The selected modules are also widely distributed
among the main branches of the Mtb VapC phylogenetic tree (Fig.
S2). Certain vapB-encoded antitoxins were reported to be induced
during infection of human macrophages (Rv0550c, Rv2009, Rv2547
and Rv3321c) [34,49]. The toxin Rv0627 and antitoxin Rv2830c
were identified as essential for growth in vitro [50], with the latter
induced by hypoxia [51]. The cluster of three vapBCmodules located
contiguously on the chromosome (Rv2545-Rv2546, Rv2547-Rv2548
and Rv2550c-Rv2549c) was selected based on the transcriptional
responsiveness of most of the genes under in-vivo-relevant conditions
[52,53,54,55,56,57] and the requirement of Rv2548 for intracellular
fitness [58]. The C-terminally truncated Rv1953 was included as a
negative control as it lacks residues comprising part of the PIN
domain and, as such, is predicted to lack nuclease activity. In addition
to the ten Mtb modules, we also included the M. smegmatis vapBC,
MSMEG_1283-MSMEG_1284, in our analysis. During the course
this study, new information on these modules became available from
other studies [31,34,40,59].
Differential growth inhibitory effects of VapC toxins in M.
smegmatis
VapC toxicity was initially assessed in M. smegmatis by conditional
expression of their encoding genes using an uncoupled system in
which the toxin was expressed from a tetracycline (Tet)-regulated
promoter (Pmyc1tetO) contained on the episomal plasmid, pSE100
[60]. In this system, repression from the Pmyc1tetO promoter in the
absence of Tet inducer was mediated by the wild type Tet-repressor
(TetR) constitutively expressed from the strong Psmyc promoter
contained on an L5-based integration vector (pMC1s) [60]. The
resulting vector pairs were co-electroporated intoM. smegmatis, and in
all cases, were found to be stable in the absence of anhydrotetracy-
cline (ATc) inducer, suggesting that vapC expression was sufficiently
repressed to avoid plasmid loss or mutation as a result of toxic gene
expression. The toxicity of the VapC proteins was assessed by
spotting dilutions of cultures on solid media containing ATc at a
concentration of 0–50 ng/ml. Of the ten VapCs assessed, only four,
namely, Rv0549c, Rv0595c, Rv2549c and Rv2829c, were growth
inhibitory inM. smegmatis at ATc concentrations.3 ng/ml; the toxic
effect of Rv0549c expression was, however, noticeably less than that
of the other VapCs (Fig. 1). No toxicity was observed following
induction of the others VapC, includingMSMEG_1284, with ATc at
concentrations up to 200 ng/ml.
The effect of ectopic VapC expression on the viability of M.
smegmatis was then assessed by inducing toxin expression during
growth in liquid media (Fig. 2). For three VapCs that were
inhibitory in the spotting assay (Rv0595c, Rv2549c and Rv2829c),
vapC induction resulted in a ca. 2-log10 reduction in CFUs after 3 h
of induction; thereafter, the CFU values stabilized before increasing
again between 10 and 24 h post-induction (Fig. 2, panels D and E).
Six randomly selected colonies from the Rv2829c-expressing strain
that grew on plates after 16 h exposure to ATc in liquid culture were
picked and phenotypically analyzed alongside colonies recovered
from an ATc-free control. All colonies from the control were
severely growth-impaired when plated on ATc confirming that
inducible VapC expression was retained in these cells. In contrast,
four clones derived from the ATc-induced sample were no longer
resistant to hygromycin (Hyg) or had lost responsiveness to ATc.
Similar results were obtained in the case of Rv0595c and Rv2549c:
all colonies recovered after prolonged ATc exposure had undergone
plasmid loss or rearrangement with concomitant loss of ATc
responsiveness of growth (data not shown). Therefore, high-level
expression of toxic VapCs exerts a selective pressure that promotes
plasmid loss or instability in M. smegmatis.
Since use of a strong promoter to drive expression of tetRmay limit
the ability to de-repress vapC expression by ATc treatment and thus
mask the activity of VapCs for which no growth inhibition was
observed, we replaced pMC1s with pMC2m, in which tetR is
expressed from an intermediate strength promoter. However, in this
configuration, no toxicity was observed for Rv0627, Rv1953,
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Rv2010, Rv2546, Rv2548, Rv3320c and MSMEG_1284, even at
the highest concentration of ATc tested (200 ng/ml) (data not
shown). The effect of fully de-repressing vapC expression was then
assessed by measuring the transformation efficiencies in M. smegmatis
of the expression vectors in the absence of TetR. The transformation
efficiencies of pSE0549c, pSE0595c, pSE2549c, pSE2829c and
pSE3320c were $3-log10 lower than the empty vector control,
pSE100 (Table S2). Of these, four were previously scored as toxic
when conditionally expressed (Rv0549c, Rv0595c, Rv2549c and
Rv2829c), whereas toxicity of Rv3320c was only revealed when this
VapC was constitutively expressed. In contrast, the transformation
efficiencies of pSE0627, pSE1953, pSE2010, pSE2546, pSE2548 and
pSESM1284 were comparable to that of pSE100 (0.08-1.3-fold),
confirming that no significant toxicity was conferred by these VapCs,
even when constitutively expressed (Table S2). We tested whether
Rv2546, Rv2548 and MSMEG_1284 may have been rendered non-
toxic through plasmid mutation/rearrangement by sequencing the
promoter-operator region and insert of plasmid recovered from
transformants obtained with and without the tetR-expressing vector.
However, in all cases, the recovered plasmid was unaltered (data not
shown).
Differential growth inhibitory effects of VapC toxins in
wild type Mtb
The effect of regulated expression of a subset of VapCs was
analyzed in wild type Mtb (Fig. 3 and data not shown). Rv0627,
Rv1953, Rv2010, Rv2546, Rv2548 and Rv3320c had no effect on
the growth of H37Rv in liquid culture (Fig. 3C, Fig. 3F and data not
shown) even though corresponding vapC transcript was detected
(Fig. 4A and data not shown). However, as observed inM. smegmatis,
only Rv0549c, Rv0595c, Rv2549c and Rv2829c were growth
inhibitory when conditionally expressed in Mtb, with Rv0549c
being the least toxic (Fig. 3, panels A, B, D and E). Moreover, while
expression of the toxic VapCs in M. smegmatis resulted in a marked
decline in CFUs after ATc induction (Fig. 2), no reduction in CFUs
was observed over a 3–4-day induction period in Mtb (Fig. 3D,
Fig. 3E and data not shown) with CFUs remaining unchanged over
this period. The effect of constitutive VapC expression in Mtb was
then assessed by measuring the transformation efficiencies of the
VapC expression vectors in the absence of a tetR-expressing partner
(Table S3). Toxicity of Rv0549c, Rv0595c, Rv2549c and Rv2829c
was revealed by reduced transformation efficiency relative to the
empty vector control. Moreover, as in M. smegmatis (Table S2),
toxicity of Rv3320c in Mtb was only revealed when this VapC was
constitutively expressed (Table S3).
Detection of VapC toxicity is influenced by the level of
expressed protein
To investigate the reasons underlying the apparent lack of
toxicity of some VapCs, transcript levels of the genes encoding the
toxic Rv2549c and non-toxic Rv2546 VapCs were compared by
RT-PCR analysis of mRNA from M. smegmatis cells cultured with
or without ATc (Fig. 4B). Expression of both genes was
significantly induced by ATc. Similar results were obtained for
the other vapCs investigated in this study (data not shown)
suggesting that the lack of toxicity was not due to a defect in gene
expression from the Tet-regulated promoter. To compare the
levels of VapC proteins induced in M. smegmatis, we tagged
Rv2549c and Rv2546 at their C-termini with the 36FLAG
epitope. Epitope-tagged Rv2549c displayed toxicity equivalent to
its native counterpart, confirming that the 36FLAG tag did not
affect the biological activity of this VapC (data not shown).
Immuno-reactive bands of the size predicted for epitope-tagged
Rv2546 and Rv2549c proteins (,17 kDa) were observed in
Western blots of cell-free extracts from M. smegmatis strains
carrying the tagged VapC expression vectors that were cultured
in the presence ATc (Fig. 4C, ‘‘+ATc’’). A 55-kDa immuno-cross-
reactive band detected in the cell-free extract of M. smegmatis
provided an internal control that allowed the levels of FLAG-
tagged VapCs to be compared between strains. The level of
Rv2546 protein was noticeably higher in cells lacking TetR than in
ATc-induced cells carrying TetR (Fig. 4C; left-hand panel, ‘‘-
TetR’’ vs. ‘‘+TetR’’ lanes). However, the level of Rv2546 under
fully de-repressed conditions was still lower than that of Rv2549c
in TetR-containing cells induced with ATc (Fig. 4C, middle and
left-hand panels). These results suggest that the level of Rv2546
might have been insufficient to cause a growth inhibitory effect in
M. smegmatis.
To further investigate the effects of VapC levels on cell viability,
we analysed the effect of epitope-tagged Rv2549c over-expression
on the growth of M. smegmatis at various concentrations of ATc,
and compared this with the level of protein expressed in cells
cultured under the same conditions. As shown previously (Fig. 1),
the toxic effect of Rv2549c expression only became evident at ATc
concentrations.3ng/ml, whereas lower concentrations of inducer
had little or no impact on the growth or viability of M. smegmatis
(Fig. 4D). Western blot analysis of cell-free extracts of M. smegmatis
cultures exposed to the same concentrations of inducer revealed an
ATc dose-dependent increase in the level of epitope-tagged
Rv2549c (Fig. 4E). Therefore, although Rv2549c is expressed at
Figure 1. Effect of mycobacterial VapC expression on growth of
M. smegmatis on solid media. Ten-fold serial dilutions of cells were
spotted on 7H10 agar without or with ATc (1.6, 6.2 and 50 ng/ml) and
incubated for 24–48 h.
doi:10.1371/journal.pone.0021738.g001
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the lower concentrations of inducer (#3 ng/ml), these results
suggest that a specific threshold must be breached in order for the
toxic activity of this VapC to become apparent in M. smegmatis.
Abrogation of VapC toxicity by cognate antitoxin
expression
To determine whether the activity of the toxic VapC proteins
could be neutralized by expression of their cognate antitoxins, we
compared the growth of M. smegmatis strains in which the vapC
gene was expressed either individually from the Pmyc1tetO
promoter, or together with its cognate vapB gene in its native
configuration as a vapBC operon. As observed previously (Fig. 1),
ATc-induced expression of the VapCs encoded by Rv0549c,
Rv0595c, Rv2549c and Rv2829c resulted in growth inhibition in the
absence of its cognate antitoxin (Fig. 5A). However, in all cases, co-
expression of the toxin together with its cognate antitoxin rescued
the growth of the strains in the presence of ATc (Fig. 5A). The
finding that VapC toxicity is abrogated by cognate VapB antitoxin
co-expression supports the notion that these proteins form
functional TA pairs in mycobacteria, and that the growth
inhibition observed in the absence of antitoxin was not due to
generalized toxicity due to protein over-expression.
We then investigated whether the ability to neutralize VapC
activity is restricted to cognate antitoxins using an uncoupled
system in which the genes encoding toxic VapCs were expressed
from the ATc-inducible promoter on a Tweety-based integration
vector [61] carrying tetR, and the antitoxins constitutively
expressed from the acetamidase promoter [62] on a L5-based
integration vector. In this configuration, growth inhibition of M.
smegmatis following ATc-induced over-expression of the Rv2549c
VapC protein was retained (Fig. 5B). The toxicity was, however,
neutralized by co-expression of its cognate VapB, Rv2550c, when
its encoding gene was integrated at a chromosomal locus distal
from that of the toxin (Fig. 5B). In contrast, expression of the non-
cognate antitoxins, Rv0596c and Rv2830c, which had previously
been shown to abolish toxicity of their cognate toxins (Fig. 5A),
had no effect on the growth inhibition caused by induction of
Rv2549c (Fig. 5B). Similarly, expression of its cognate VapB,
Rv0596c, alleviated the toxicity of Rv0595c in the presence of
ATc whereas expression of Rv2550c or Rv2830c had no effect
(data not shown). Together, these data confirm that the activity of
VapC toxins can only be neutralized by their cognate antitoxins.
Specificity of VapC interaction with cognate VapB
confirmed by yeast-two hybrid (Y2H) analysis
The interaction between cognate vs. non-cognate VapC and
VapB proteins was further analyzed by Y2H analysis (Fig. 6). In
this assay system, the VapC, Rv0595c, was found to interact
specifically with its cognate VapB, Rv0596c as evidenced by
growth of the corresponding yeast strains on high-stringency
media. In contrast, no interaction was observed between Rv0595c
and the non-cognate VapBs, Rv2550c and Rv2830c, or between
Rv0596c and the non-cognate VapC, Rv2549c. Similar results
were obtained for Rv2549c, which interacted specifically with
Rv2550c, but showed no detectable interaction with the non-
cognate VapBs, Rv2830c and Rv0596c. These results indepen-
dently confirm the specificity of cognate VapB-VapC interaction
deduced from the toxicity neutralization data and suggest that
spurious interactions between non-cognate VapB-VapC pairs may
not be functionally relevant in the native host.
Effect of vapBC loss on susceptibility to cognate vapC-
mediated toxicity
To investigate the role of the vapBC TA modules in the
physiology of mycobacteria, unmarked Mtb deletion mutants
lacking the vapC, Rv0595c, the vapBC, Rv2009-Rv2010, or the three
contiguous vapBC modules, Rv2545-Rv2546, Rv2547-Rv2548 and
Rv2550c-Rv2549c, were generated by allelic exchange mutagenesis.
In addition, a M. smegmatis mutant lacking the MSMEG_1283-
MSMEG_1284 module was constructed. None of the strains
displayed a growth defect relative to the wild type when cultured
under standard conditions in either liquid medium or on agar
plates (data not shown). The susceptibility of the M. smegmatis
vapBC mutant to cell wall, oxidative, nitrosative, genotoxic and
heat stress was also assessed and found to be indistinguishable from
wild type under all conditions tested (data not shown).
To assess the effect of loss of vapB function on the susceptibility
of Mtb to growth inhibition by cognate or non-cognate vapC
expression, we compared the transformation efficiencies of the
vapC expression vectors in the DRv2545-Rv2550c mutant and wild
type strains (Table S3). Neither Rv2546 nor Rv2548 was toxic
when expressed in the mutant strain, which lacks their cognate
vapB genes. Similarly, no toxicity was observed when
MSMEG_1284 was conditionally or constitutively expressed in
wild type M. smegmatis or the deletion mutant lacking the
MSMEG_1283-MSMEG_1284 module. In contrast, an exacerba-
tion of Rv2549c toxicity in the absence of its cognate antitoxin was
revealed by comparing its effects on growth and viability in Mtb
when conditionally expressed in liquid cultures of the wild type vs.
DRv2545-Rv2550c strains (Fig. 7). Expression of Rv2549c was
growth inhibitory in wild type Mtb (Figs. 7A and B); however, a
10-fold reduction in CFUs was observed within two days of
induction of Rv2549c expression in the mutant strain (Figs. 7C and
D). As in M. smegmatis, the outgrowth observed subsequent to the
early killing of the DRv2545-Rv2550c mutant upon induction of
Rv2549c expression was due to abrogation of toxicity by plasmid
rearrangement or loss (data not shown).
The VapCs Rv0065 and Rv0617 display sequence-
selective RNase activity
To investigate the mechanism underlying VapC toxicity in
mycobacterial hosts, we sought to biochemically characterize five
VapCs analyzed in this study (Rv0549c, Rv0595c, Rv2546,
Rv2549c and Rv2829c). In general, mycobacterial VapC proteins
cannot be expressed in E. coli due to a combination of their
insolubility and toxicity (J.L.M & V.A., unpublished observations).
Thus, the VapCs were expressed in M. smegmatis [59,63] as tagged
fusion protein complexes with their cognate VapBs. The Rv0596c-
Rv0595c and Rv2830c-Rv2829c complexes did not express in M.
smegmatis, and the other three complexes did express but the
proteins were insoluble after cell lysis (Rv0550c-Rv0549c,
Rv2545-Rv2546 and Rv2550c-Rv2549c). In contrast, the related
VapBC complexes Rv0065A-Rv0065 and Rv0616A-Rv0617
expressed in a soluble form and could be purified. Since Rv0065
is closely related to Rv0549c, sharing 36% amino acid identity and
50% amino acid similarity with Rv0549c (Fig. S2) and Rv0617
Figure 2. Variable effects of Mtb VapC over-expression on growth and viability of M. smegmatis in liquid culture. Growth and viability
were assessed spectrophotometrically (A, B, C) and by CFU enumeration (D, E, F). Open symbols represent ATc-induced samples and filled symbols
represent uninduced controls. The results represent the average and standard deviations from one of three independent experiments.
doi:10.1371/journal.pone.0021738.g002
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shares 38% sequence identity and 55% sequence similarity with
Rv3320c, we reasoned that these VapCs could serve as useful
models for analyzing the biochemical function of a toxic
mycobacterial VapCs. Limited proteolysis of the VapBC complex
resulted in selective degradation of the unstable VapB allowing
purification of Rv0065 and Rv0617 alone. As shown in Fig. 8,
these purified proteins show Mg2+-dependent sequence-selective
RNase activity on a single-stranded RNA substrate. This RNase
activity is completely inhibited when the VapC proteins are in
complex with their cognate VapBs.
Discussion
In this study, the function of a representative subset of
mycobacterial VapBC modules was investigated in M. smegmatis
and Mtb. VapC toxicity was initially assessed using a modular
system in which vapC expression was either constitutive (in the
absence of TetR) or conditionally regulated by TetR as a function of
inducer concentration or the level of tetR expression. Of the VapCs
tested, five were growth inhibitory in M. smegmatis, with Rv0549c
being noticeably less toxic than Rv0595c, Rv2549c and Rv2829c
when conditionally expressed, and Rv3320c only displaying toxicity
when constitutively expressed. The five VapCs that were growth
inhibitory inM. smegmatis demonstrated the same differential toxicity
in wild type Mtb, with Rv0549c displaying only modest growth
inhibition when expressed conditionally or constitutively, and
Rv3320c being most toxic, but only when expressed constitutively.
Conditional expression of the three Mtb VapCs that were most
toxic in M. smegmatis (Rv0595c, Rv2549c and Rv2829c) resulted in
a rapid initial decline in bacterial CFUs, suggestive of VapC-
mediated cell death or protracted bacteriostasis. Selection against
VapC toxicity in M. smegmatis was revealed by loss or rearrange-
ment of the expression vector to eliminate vapC expression in cells
that survived toxic VapC exposure. Although the same three
VapCs were growth inhibitory in Mtb, their effects were
bacteriostatic in this host. However, a bactericidal effect in Mtb
was observed by conditional expression of Rv2549c in a mutant
strain that lacks the cognate Rv2550c antitoxin, confirming that
VapC toxicity in Mtb can be tempered by expression if its cognate
antitoxin from the corresponding vapBC module on the chromo-
some. In line with this observation, co-expression of the cognate
vapB on an operon with vapC abrogated toxicity of all VapCs that
were growth inhibitory in M. smegmatis. The specificity of toxin
neutralization by the cognate VapB was demonstrated using an
uncoupled system in which vapC and vapB genes were conditionally
expressed under control of different regulatable promoters and
from distinct chromosomal loci. In this assay, VapC-induced
growth inhibition was specifically neutralized in M. smegmatis
expressing the cognate vapB; in contrast, expression of non-cognate
vapBs was ineffective. Together with the enhanced toxicity of
Rv2549c in a mutant of Mtb that lacks the cognate antitoxin
(Rv2550c), and the specificity of interaction between cognate
VapB-VapC pairs revealed by Y2H analysis, our results argue
against (functionally relevant) interactions between the toxin and
antitoxin components of different VapBC modules in Mtb,
consistent with findings from another study [34].
The lack of toxicity of Rv1953 under all conditions tested was
consistent with the predicted abrogation of nuclease activity in this
C-terminally truncated protein. In contrast, the reason for the lack
of toxicity of Rv0627, Rv2010, Rv2546 and Rv2548 following
expression in both Mtb and M. smegmatis was less clear. During the
course of our study, the effects of toxin expression on the growth of
E. coli, M. smegmatis and/or Mtb hosts were reported by other
groups [38,40,43,44]. Although some concordance exists, there
are many differences between studies, even when the same host
organism was employed for assessing toxicity. For example,
Rv0627 was non-toxic in M. smegmatis and Mtb in our study,
and in M. smegmatis in that of Ramage et al. [34], but this VapC
was reported by Miallau et al. [31] as toxic in Mtb and M.
smegmatis. Similarly, we found Rv0595c, Rv2549c and Rv3320c to
be toxic in M. smegmatis, but Ramage et al. [34] did not, whereas
the converse was true for Rv2010 and Rv2548 which were scored
as toxic in that study, but not in the present one. Moreover, while
Robson et al. reported growth inhibition of M. smegmatis by
conditional expression of MSMEG_1284 [59], no such effect was
observed in either wild type M. smegmatis or a deletion mutant
lacking the MSMEG_1283-MSMEG_1284 module in this study.
These discrepancies may be due to differences in expression
vectors, translation initiation signals, growth conditions and/or
host strains used for VapC over-expression, which could result in
assay-dependent biases. One or more of these factors may
preclude the detection of toxin-induced growth inhibition if
insufficient levels of the protein are produced following over-
expression, leading to the incorrect classification of a subset of
VapC as ‘non-toxic’. Our observations suggest that the reduced
level of Rv2546 relative to Rv2549c might explain why this was
non-toxic in our assay system, a notion substantiated by the
finding that the toxicity of Rv2549c was only evident once the level
of induced protein exceeded a certain threshold. Such factors
clearly complicate distinguishing ‘functional’ TA modules from
others, and suggest that the list of 30 modules defined as ‘toxic’ is
likely an under-representation, biased by assay-dependent effects,
as postulated [34].
The five VapCs identified as toxic in this study proved to be
refractory to expression in a soluble form when complexed with
their cognate VapCs, and as such, could not be isolated in a form
suitable for biochemical analysis. Nonetheless, we were able to
isolate and purify the Rv0549c homolog, Rv0065 and the
Rv3320c homolog, Rv0617, respectively, and demonstrate that
they have sequence-selective RNase activity. This finding strongly
implies an association between VapC toxicity and translational
inhibition as a result of RNA cleavage in mycobacteria, and
moreover, suggests that the vapBC family provides a potentially
abundant source of RNase activity in Mtb that might vary as a
function of regulated expression of individual modules, and/or
the rates of antitoxin degradation. The effects of extensive and
variable nuclease activity on the biology of Mtb are likely to be
profound and underscore the importance of identifying the
cellular target(s) of VapCs in Mtb. Such studies are likely to
provide valuable insights into the physiological role(s) that this
family of proteins plays in the biology of this major human
pathogen.
Figure 3. Variable effects of Mtb VapC expression on growth and viability of wild type Mtb in liquid culture. A, B, C: Growth was
assessed spectrophotometrically for a period of 6 days after induction of gene expression, as described under Materials and Methods. Open symbols
represent ATc-induced samples and filled symbols represent uninduced controls. The results show the data from one of three independent
experiments. D, E, F: Viability was assessed by enumerating CFU. Open bars, CFU prior to induction of gene expression (day 0); black bars, untreated
control (day 3); and striped bars, ATc-treated culture (day 3). The results show the average CFU values from duplicate platings at one serial dilution
from one of three independent experiments.
doi:10.1371/journal.pone.0021738.g003
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Figure 4. Analysis of ATc-regulated vapC expression in mycobacteria. Expression was analyzed by RT-PCR (A and B) and detection of
expressed proteins by epitope tagging (C). RT-PCR was carried out using mRNA samples obtained from (A) induced cultures of wild type Mtb (6 h
treatment with ATc at 25 ng/ml); and (B) ATc-induced and uninduced cultures of M. smegmatis (1 h treatment with ATc at 50 ng/ml) over-expressing
various vapC toxins under the control of the Pmyc1tetO promoter. Samples obtained with (+) and without (-) reverse transcription (RT) were compared
to distinguish cDNA from genomic DNA contamination. (C) Cellular fractions isolated from M. smegmatis were subjected to Western blot analysis
using the anti-FLAG M2 antibody to detect the epitope-tagged VapC Rv2546 and Rv2549c proteins. Cultures were grown in either the presence (+) or
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Materials and Methods
Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids used in this study are
described in Table S4. Unless otherwise indicated, M. smegmatis
strains were grown in Difco Middlebrook 7H9 media (BD)
supplemented with 0.085 % NaCl, 0.2 % glucose, 0.2 % glycerol
and 0.05 % Tween 80 or on solid Difco Middlebrook 7H10 media
(BD) supplemented with 0.085 % NaCl, 0.2 % glucose and 0.5 %
glycerol. Mtb strains were grown in Middlebrook 7H9 media
supplemented with 0.2 % glycerol, Middlebrook oleic acid-
albumin-dextrose-catalase (OADC) enrichment (Merck) and 0.05
% Tween 80. Hygromycin (Hyg), kanamycin (Km) and gentamy-
cin (Gm) were used in mycobacterial cultures at final concentra-
tions of 50, 25 and 5 mg/ml, respectively. ATc (Sigma) inducer
was used at concentrations up to 200 ng/ml.
Construction of deletion mutant strains
A 6097 bp EcoRI/Asp718 fragment carrying Rv2009-Rv2010
was excised from BacD8 [64] and inserted in pGEM3Zf(+). An
upstream homologous fragment was obtained by subcloning a
2455 bp PstI fragment in pGEM3Z(+)f. A 3143 bp downstream
homologous fragment was excised from the BacD8 subclone by
digestion with BsDRI and PstI and cloned in the XbaI site of the
vector carrying the upstream fragment. The resulting deletion
allele was excised as a 5654 bp HindIII/Asp718 fragment and
absence (-) of 50 ng/ml ATc for 3 h. (D) The effect of epitope tagged Rv2549c expression on the growth of M. smegmatis on solid media. Ten-fold
serial dilutions of cells were spotted on 7H10 agar without or with the ATc (1, 2, 3 and 50 ng/ml) and incubated for 24–48 h. (E) Comparison of the
relative abundance of Rv2549c induced with varying concentrations of ATc. Cultures were grown in either the presence (+) or absence (2) of 50 ng/
ml ATc for 3 h. Equal amounts (3 mg) were subjected to Western blot analysis using the anti-FLAG M2 antibody to detect the epitope-tagged Rv2549c
protein.
doi:10.1371/journal.pone.0021738.g004
Figure 5. Neutralization of Mtb VapC toxicity in M. smegmatis by cognate antitoxin expression. A: Cognate toxin-antitoxin modules were
co-expressed as an operon under control of the Tet-regulated promoter. Serial dilutions were plated on 7H10 agar alone (-ATc) or with ATc at 25 ng/
ml (+ATc). B: Toxin and antitoxin genes were expressed separately on Tweety (vapC) or L5-based integration vectors (vapB) under control of Tet- or
acetamide-regulated promoters, respectively. Serial dilutions were plated on 7H10 agar alone or supplemented with Gm and Km, or Gm and ATc
(50 ng/ml).
doi:10.1371/journal.pone.0021738.g005
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inserted in p2NIL before introducing the lacZ-sacB-hyg cassette
from pGOAL19 to produce p2D2009_10KO. This vector was
used to construct a mutant of Mtb in which the last 78 amino
acids of the antitoxin (Rv2009, containing the DNA binding
motif) and all except the C-terminal 33 amino acids of the toxin
(Rv2010) were removed. Suicide plasmids for generating other
deletion mutants were constructed by PCR amplification from
genomic DNA of upstream and downstream homologous
sequences including the 59 and 39 termini of the gene of interest
using primer pairs described in Table S5. Amplicons were
cloned in pGEM3Z(+)f and sequenced before sub-cloning the
corresponding upstream and downstream fragments in p2NIL
to create deletion alleles. The lacZ-sacB-hyg cassette from
pGOAL19 was inserted in the p2NIL subclones to create
p2D0595cKO, and p2D2545_50cKO as suicide substrates for
introducing unmarked deletions in Mtb Rv0595c and Rv2545-
Rv2550c, and p2DSM1283_84KO as a substrate for generating
an unmarked deletion in MSMEG_1283-MSMEG_1284 (Table
S4). Suicide vectors were electroporated into Mtb H37Rv or M.
smegmatis mc2155 and allelic exchange mutants recovered by
two-step selection, as described [65]. Mutant genotypes were
confirmed by Southern blot analysis.
Construction of vectors for conditional expression of
toxins and antitoxins in mycobacteria
VapC toxin-encoding sequences were amplified by PCR from
Mtb H37Rv chromosomal DNA using the primers listed in Table
S6. In all cases, ribosome binding sites were changed to a
standardized consensus sequence (GGAAG/A) in order to optimize
the yield of expressed protein [66]. For cloning downstream of the
Pmyc1tetO promoter-operator element and ATc-dependent regula-
tion of expression [60], Rv0549c, Rv0595c, Rv2829c, Rv1953 were
expressed as BamHI/PstI fragments, Rv2546, Rv2548, Rv2549c
were expressed as BamHI/HindIII fragments, and Rv0627 was
expressed as a PstI-HindIII fragment and cloned in pSE100. The
MSMEG_1284 ORF was cloned in the PvuII site of pSE100.
Derivatives of Rv2546 and Rv2549c containing a C-terminal
36FLAG epitope tag were expressed using the same forward primer
as for the native version, and a modified reverse primer containing
the 36 FLAG peptide-encoding sequence (Table S6). To ensure
efficient translation of the expressed VapC proteins following ATc-
induction, a consensus RBS (GGAAG/A) [66] was included
upstream of the start codon of the vapC genes in those instances
where an endogenous ribosome-binding site (RBS) was not clearly
discernible. Other than this modification, the promoter architecture
and start codons of the native vapC genes were preserved.
Vectors for expression of the vapBC modules Rv0550c-Rv2549c,
Rv0596c-Rv0595c, Rv2550c-Rv2549c and Rv2830c-Rv2829c were
generated using a vapB-specific forward primer and the reverse
primer used for expression of the corresponding vapC (Table S6). All
expression constructs were confirmed by DNA sequencing, and
electroporated intoM. smegmatis or Mtb alone or with an integrative
tetR-containing plasmid in which tetR is expressed under control a
strong (pMC1s) or intermediate strength promoter (pMC2m) [60].
Transformants were selected on 7H10 agar supplemented with Hyg
or Hyg and Km respectively.
Vectors for uncoupled, regulated expression of the Rv2549c and
either cognate (Rv2550c), or non-cognate VapB antitoxins (Rv2830c,
Rv0596c) were constructed as follows. The L5-based integrative
vector, pMC1s [60], was digested with NotI and the vector backbone
re-ligated to generate pMC1r. The acetamide-inducible acetamidase
promoter from M. smegmatis [62] was cloned in pMC1r to produce
pMAP. The antitoxin-encoding genes, Rv2550c, Rv0595c and
Rv2830c, were PCR-amplified (Table S6) and cloned in pMAP to
produce pMAP2550c, pMAP0595c and pMAP2830c, respectively.
The Tweety-based integration vector [61], pTTP1BG, was prepared
Figure 6. Y2H analysis of VapC-VapB interactions. Interactions between VapCs and either cognate or non-cognate VapBs were tested by co-
transformation and scoring for growth on selection (LT) vs. media of differing stringency. Three independent colonies of each strain were re-
suspended in sterile water, the cell density adjusted to an OD600 of 1 and aliquots spotted on plates. LT, Leu-Trp; LTH, Leu-Trp-His; LTHA, Leu-Trp-His-
Ade dropout-supplemented media.
doi:10.1371/journal.pone.0021738.g006
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by digesting pTTP1B [61] with HindIII, re-ligation of the vector and
insertion of a GmR cassette [67] in the PstI site. A NotI fragment from
pMC1s carrying the Psmyc-tetR element was cloned in the SmaI site of
pTTP1BG followed by cloning of the 883-bp SpeI/ClaI fragment
from pSE2549c which carries the Pmyc1tetO::Rv2549c element in the
EcoRI site of the resulting vector to produce pTT2549c. This vector
was electroporated into M. smegmatis alone or together with each of
the antitoxin-expressing pMAP subclones.
Effect of conditional overexpression of VapCs on
mycobacterial growth and viability
VapC toxicity was assessed both on solid medium and in liquid
culture in M. smegmatis and in liquid culture only in Mtb. For the
M. smegmatis plating assay, transformants were grown in Mid-
dlebrook 7H9 media containing Hyg and Km to an OD600 of
approximately 1.0. The cultures were diluted in a 10-fold series
and spotted on 7H10 plates with or without varying concentra-
tions of ATc. The plates were incubated at 37uC and the growth
checked after 24 and 48 h. For toxicity assessment in liquid
culture, M. smegmatis transformants were grown in Middlebrook
7H9 media containing Km and Hyg to an OD600 of 0.1 - 0.4 and
diluted into fresh warm media to an OD600 of 0.1. The cultures
were split and either treated with ATc (25 ng/ml; induced) or left
untreated (uninduced). The OD600 of each culture was measured
every 2 h and viability scored by plating, in duplicate, serial
dilutions of samples taken every 4 h over a period of 25 h.
Mtb transformants were grown in Middlebrook 7H9 media
containing Hyg and Km to an OD600 of 0.1. The cultures were
diluted to an OD600 of 0.04 and left to grow overnight before being
split into two equal aliquots which were treated with ATc (25 or 50 ng/
ml – induced) or left untreated (uninduced). Growth and viability were
assessed by periodically monitoring OD600 and CFUs over 6 d.
Stress sensitivity testing
The susceptibility of the M. smegmatis vapBC mutant to various
stresses was tested using previously described methods [52,68,69,70].
Figure 7. Rv2549c displays increased toxicity in the DRv2545-Rv2550c mutant strain of Mtb. Growth and viability were assessed
spectrophotometrically (A, C) and by CFU enumeration (B, D). Open symbols represent ATc-induced samples and filled symbols represent
uninduced controls. The results represent the average and standard deviations from three independent experiments.
doi:10.1371/journal.pone.0021738.g007
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Analysis of gene expression by RT-PCR
RNA was extracted from early log-phase cultures, as described
[71]. Samples were treated twice with Turbo DNase (Ambion) and
RT-PCR performed with the Phusion RT-PCR kit (Finnzymes)
according to the manufacturer’s instructions. Primers for RT-PCR
analysis of expression of Mtb vapCs were designed using Primer 3
software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.
cgi) and are described in Table S6. Expression of M. smegmatis sigA
was detected as described previously [72].
Detection of FLAG-tagged proteins by Western blot
analysis
M. smegmatis cells containing 36FLAG-tagged VapC fusion
proteins were grown in 90 ml cultures to mid log-phase
(OD600,0.4–0.5) and split equally. One 45-ml aliquot was treated
with ATc (50 ng/ml) and the other served as the uninduced control.
After 3 h induction, 20 ml of cells were harvested and resuspended
in 250 ml of Bacterial Protein Extraction Reagent (B-PER II
Reagent, Thermo Scientific) containing complete mini protease
inhibitor cocktail (Roche). The cells were lysed three times for 20 s
at speed 6 using the Savant Fastprep FP120 (BIO101), with 5 min
intervals between pulses when the cells were cooled on ice. The
protein concentration was determined using a Bradford assay and
equivalent amounts of soluble and insoluble fractions of each
induced and uninduced sample were resolved on an SDS-PAGE gel
and the proteins transferred to a PVDF membrane (Amersham).
The membrane was incubated with the HRP-conjugated mouse
Anti-FLAG M2 antibody (Sigma) and the FLAG-tagged proteins
proteins were detected using the ProteoQwestTM chemiluminescent
Western blotting kit (Sigma).
Y2H analysis
Y2H analysis was performed using the Clontech Matchmaker
Y2H system and vectors carrying the VapCs, Rv0595c and
Rv2549c, or VapBs Rv0596c, Rv2550c, and Rv2830c, cloned as
GAL-4 Activation Domain (AD) and/or Binding Domain (BD)
fusions (Table S4). Interactions between selected VapC toxins and
cognate vs. non-cognate VapB antitoxins were assessed according
to the manufacturer’s instructions.
Expression, purification and biochemical analysis of
recombinant Rv0065 and Rv00617
The ORFs encoding the vapBC operons Rv0065A-Rv0065 and
Rv0616A-Rv0617 were amplified from Mtb H37Ra genomic DNA.
Importantly, there are no differences in sequence between H37Rv
and H37Ra in these regions. Moreover, the antitoxins for Rv0065
and Rv0617, which are designated herein as Rv0065A and
Rv0617A, are not annotated in the H37Rv genome. However, these
antitoxins are annotated in the H37Ra, BCG and CDC5115
genomes: Rv0065A corresponds to BCG0095A and Rv0617A
corresponds to MT0645.2. The amplicons were digested with
NcoI/HindIII restriction enzymes, purified and inserted into the
pYUB28b shuttle vector [63] enabling expression of a C-terminal
His-tag on VapC. The pYUBRv0065A-5 and pYUBRv0616A-6
constructs were then transformed into M. smegmatis mc24517 cells.
Rv0065A-Rv0065 and Rv0616A-Rv0617 VapBC complexes were
expressed and purified as previously described for the VapBC
complex from M. smegmatis [59]. VapBC complexes were digested
with trypsin to remove VapB. Digestion reactions were stopped by
addition of trypsin inhibitor from soybean and VapC was
subsequently purified using anion exchange chromatography. RNA
was transcribed from a ‘pentaprobe’ PCR product [73] using the T7
MEGAscriptH kit (Ambion, USA) according to manufacturer’s
instructions. RNase activity assays for VapC proteins contained
1 mg purified VapC protein, 1 mg purified RNA, 12 mM sodium
phosphate buffer, 6 mM NaCl and 6 mMMgCl2. Negative controls
included addition of 12 mM EDTA and substitution of VapBC for
VapC. Time course assay reactions were stopped by the addition of
10 ml formamide loading dye and heated to 70uC before loading onto
a 10% urea-denaturing PAGE gel.
Supporting Information
Figure S1 Multiple sequence alignment of mycobacte-
rial VapCs. Sequences were aligned using the ClustalW2
multiple sequence alignment tool at the European Bioinformatics
Institute website, http://www.ebi.ac.uk/Tools/clustalw2/index.
html.
(PDF)
Figure 8. The VapCs Rv0065 and Rv0617 have RNase activity.
VapC proteins Rv0065 and Rv0617 display sequence-selective RNase
activity against an RNA substrate of ,150 bases in the presence of
6 mM MgCl2. Activity is Mg
2+-dependent as addition of 12 mM EDTA
abolishes activity (lane 4). Ribonuclease activity is also inhibited in the
presence of VapB (lane 9). Addition of VapC (+VapC) results in
degradation of the RNA substrate over a period of 5 – 60 minutes
(lanes 5–8). RNA only controls (-VapC) show no contaminating
ribonuclease activity (lanes 2 & 3). The molecular weight marker shows
molecular masses of single-stranded RNA in number of bases (lane 1).
doi:10.1371/journal.pone.0021738.g008
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Figure S2 Phylogenetic tree of VapC proteins from
mycobacteria. VapCs were aligned using ClustalW2 multiple
sequence and server alignment server (http://www.ebi.ac.uk/
Tools/clustalw2/index.html). The tree was generated in Jalview
2.08.1 based on percentage identity between sequences.
(PDF)
Table S1 Properties of mycobacterial vapBC toxin-antitoxin
modules selected for study.
(PDF)
Table S2 VapC toxicity in M. smegmatis mc2155 assessed by
transformation efficiency of VapC expression vector.
(PDF)
Table S3 VapC toxicity in Mtb assessed by transformation
efficiency of VapC expression vector.
(PDF)
Table S4 Strains and plasmids used in this study.
(PDF)
Table S5 Oligonucleotides used to create knockout vectors for
allelic exchange mutagenesis.
(PDF)
Table S6 Oligonucleotides used for expression vector construc-
tion, yeast two-hybrid (Y2H) vector construction and RT-PCR.
(PDF)
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